These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 338269)

  • 1. Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation.
    Levine IM; Jossmann PB; DeAngelis V
    Dis Nerv Syst; 1977 Dec; 38(12):1011-5. PubMed ID: 338269
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.
    Basmajian JV; Yucel V
    Am J Phys Med; 1974 Oct; 53(5):223-8. PubMed ID: 4153338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lioresal in the treatment of spasticity].
    Duma-Drzewińska A; Kiwerski J; Makowski J
    Pol Tyg Lek; 1976 Jul; 31(29):1259-62. PubMed ID: 948473
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind study of progabide in spasticity].
    Bovier P; Cambier J; Morselli PL
    Therapie; 1985; 40(3):181-5. PubMed ID: 4012663
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological rebound: a tool in the evaluation of antispasticity drugs.
    Roussan MS; Abramson AS; Levine SA; Feibel A
    Arch Phys Med Rehabil; 1976 Nov; 57(11):504-7. PubMed ID: 791192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Dantrium on spasticity in spinal cord injuries.
    Jonsson B; Ladd H; Dahllöf AG
    Scand J Rehabil Med; 1975; 7(2):61-4. PubMed ID: 1162300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lioresal (baclofen) treatment of spasticity in multiple sclerosis.
    Basmajian JV
    Am J Phys Med; 1975 Aug; 54(4):175-7. PubMed ID: 1098477
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of flexor spasms with Lioresal.
    Shahani BT; Young RR
    Arch Phys Med Rehabil; 1974 Oct; 55(10):465-7. PubMed ID: 4153400
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].
    Jerusalem F
    Nervenarzt; 1968 Nov; 39(11):515-7. PubMed ID: 4884753
    [No Abstract]   [Full Text] [Related]  

  • 13. The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative.
    Lapierre YD; Elie R; Tetreault L
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1059-68. PubMed ID: 4154825
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study.
    Herman RM; D'Luzansky SC; Ippolito R
    Clin J Pain; 1992 Dec; 8(4):338-45. PubMed ID: 1493344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity.
    Burke D; Gillies JD; Lance JW
    Proc Aust Assoc Neurol; 1971; 8():131-4. PubMed ID: 4949207
    [No Abstract]   [Full Text] [Related]  

  • 17. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 18. [New treatments of spasticity (pyramidal hypertonia)].
    Truelle JL; Pelier-Cady MC; Chanelet J; Emile J
    Sem Hop Ther; 1974 Nov; 50(9):603-5. PubMed ID: 4156609
    [No Abstract]   [Full Text] [Related]  

  • 19. [MK-130, a new drug for the treatment of muscular hypertonia. Preliminary trial in 10 patients with spasticity of spinal origin].
    Molina-Negro P; Illingworth RA
    Union Med Can; 1971 Oct; 100(10):1947-51. PubMed ID: 5142212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.